A cross-sectional study
Globally, pharmaceutical manufacturers offer patient support programs (PSPs) to accompany their products, which aim to enhance medication adherence and patient experience through education, training, support and financial assistance. The limited research available on PSPs relies on data generated from the programs themselves and are primarily funded and conducted by the drug’s manufacturer. There remains little understanding of manufacturer-sponsored PSPs and the extent or nature of the services provided, making it difficult to assess the value to patients or their impact within health systems.
This study identified the proportion and characteristics of marketed prescription drugs with a manufacturer-sponsored PSP and the nature of supports provided.
Access the full article and associated resources: